Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 17/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | CTSV | O60911 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4795142 | 1.00 | SLC6A9 (0.64) | SLC6A9CTSSCTSKCTSVCTSL | |
| SCHEMBL4795151 | 1.00 | SLC6A9 (0.64) | SLC6A9CTSSCTSKCTSVCTSL | |
| SCHEMBL4781763 | 0.94 | SLC6A9 (0.66) | SLC6A9CTSSCTSKCTSVCTSL | |
| SCHEMBL4781754 | 0.94 | SLC6A9 (0.66) | SLC6A9CTSSCTSKCTSVCTSL | |
| SCHEMBL4794579 | 0.92 | SLC6A9 (0.69) | SLC6A9 | |
| SCHEMBL4794575 | 0.92 | SLC6A9 (0.69) | SLC6A9 | |
| SCHEMBL4794833 | 0.91 | SLC6A9 (0.64) | SLC6A9CTSSCTSK | |
| SCHEMBL4794836 | 0.91 | SLC6A9 (0.64) | SLC6A9CTSSCTSK | |
| Hydrochloric Acid SCHEMBL4794871 | 0.91 | SLC6A9 (0.68) | SLC6A9 | |
| Hydrochloric Acid SCHEMBL4794867 | 0.91 | SLC6A9 (0.68) | SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008018639-A2 | GLYCINE TRANSPORTER INHIBITOR | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-02-14 | — | — | WO | disclosed |
| WO-2008018639-A2 | GLYCINE TRANSPORTER INHIBITOR | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-02-14 | — | — | WO | disclosed |